Black Diamond Therapeutics, Inc. (BDTX) Balance Sheet
BDTX balance sheet, 2025
December 31, 2025 · U.S. dollars$143.0M assets = $30.8M liabilities + $112.2M equity
Both columns are drawn to the same scale: what BDTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BDTX financial health
Descriptive bands, not a rating. Fiscal 2025.
BDTX balance sheet trends, 2017–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $8.0M2017 | $143.0M2025 | +43.3%/yr | |
| Total liabilities | $14.7M2017 | $30.8M2025 | +9.7%/yr | |
| Shareholders’ equity | −$6.7M2017 | $112.2M2025 | — | |
| Cash & short-term investments | $7.9M2017 | $128.7M2025 | +41.8%/yr | |
| Total debt | $12.5M2017 | $18.8M2025 | +5.3%/yr | |
| Net cash (debt) | −$4.6M2017 | $109.9M2025 | +$114.5M | |
| Working capital | $5.7M2017 | $116.7M2025 | +$111.0M | |
| Book value per share | −$1.112018 | $1.952025 | — | |
| Current ratio | 3.552017 | 8.422025 | +4.87 | |
| Debt / equity | 0.032020 | 0.172025 | +0.14 | |
| Shares outstanding | 14.0M2018 | 57.6M2025 | +22.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BDTX assets
BDTX liabilities and equity
BDTX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BDTX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $128.7M | $98.6M | $131.4M | $122.8M | $209.8M | $315.1M | $154.7M | $51.7M | $7.9M |
| Cash & equivalents | $21.0M | $36.4M | $56.2M | $34.3M | $65.8M | $34.6M | $154.7M | $51.7M | $7.9M |
| Short-term investments | $107.7M | $62.1M | $75.2M | $88.5M | $144.0M | $280.5M | — | — | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $3.8M | $2.6M | $2.6M | $4.9M | $5.9M | $4.5M | $1.0M | $24,000 | $36,000 |
| Total current assets | $132.4M | $101.2M | $134.0M | $127.7M | $215.7M | $319.6M | $155.7M | $51.7M | $7.9M |
| Property, plant & equipment (net) | $9.7M | $20.4M | $23.7M | $27.4M | $30.7M | $8.8M | $164,000 | $134,000 | $102,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $902,000 | $1.1M | $823,000 | $1.2M | $1.2M | $1.3M | $2.4M | $8,000 | $5,000 |
| Total assets | $143.0M | $122.6M | $158.6M | $156.3M | $247.7M | $329.7M | $158.3M | $51.8M | $8.0M |
| Liabilities | |||||||||
| Accounts payable | $579,000 | $4.0M | $2.3M | $1.9M | $4.1M | $2.5M | $2.0M | $416,000 | $152,000 |
| Short-term debt | $3.7M | $3.4M | $3.1M | $2.8M | $320,000 | $1.0M | — | — | — |
| Total current liabilities | $15.7M | $20.6M | $19.6M | $15.3M | $23.6M | $14.2M | $4.9M | $2.6M | $2.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $18.8M | $22.2M | $25.3M | $28.1M | $28.5M | $8.7M | — | — | — |
| Other long-term liabilities | $15.1M | $18.8M | $22.2M | $25.3M | $28.1M | $7.7M | $200.6M | $64.8M | $12.5M |
| Total liabilities | $30.8M | $39.4M | $41.8M | $40.6M | $51.8M | $21.9M | $205.5M | $67.4M | $14.7M |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $8,000 | $7,000 | $7,000 | $5,000 | $5,000 | $5,000 | $1,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$464.7M | −$487.1M | −$417.4M | −$335.0M | −$243.8M | −$118.2M | −$51.0M | −$15.7M | −$6.8M |
| Accumulated other comprehensive income | $101,000 | $24,000 | −$27,000 | −$1.8M | −$414,000 | $614,000 | −$112,000 | −$100,000 | −$56,000 |
| Total shareholders' equity | $112.2M | $83.3M | $116.7M | $115.7M | $195.9M | $307.8M | −$47.2M | −$15.5M | −$6.7M |
| Key figures | |||||||||
| Total debt | $18.8M | $22.2M | $25.3M | $28.1M | $28.5M | $8.7M | $200.6M | $60.8M | $12.5M |
| Net cash (debt) | $109.9M | $76.4M | $106.1M | $94.7M | $181.3M | $306.3M | −$45.9M | −$9.1M | −$4.6M |
| Working capital | $116.7M | $80.6M | $114.4M | $112.4M | $192.1M | $305.3M | $150.9M | $49.1M | $5.7M |
| Tangible book value | $112.2M | $83.3M | $116.7M | $115.7M | $195.9M | $307.8M | −$47.2M | −$15.5M | −$6.7M |
| Book value per share | $1.95 | $1.51 | $2.66 | $3.19 | $5.41 | $9.35 | −$1.31 | −$1.11 | — |
| Shares outstanding | 57.6M | 55.0M | 44.0M | 36.2M | 36.2M | 32.9M | 35.9M | 14.0M | — |
| Current ratio | 8.42 | 4.92 | 6.82 | 8.37 | 9.12 | 22.48 | 32.02 | 20.07 | 3.55 |
| Quick ratio | 8.18 | 4.79 | 6.69 | 8.05 | 8.87 | 22.16 | 31.80 | 20.06 | 3.53 |
| Debt / equity | 0.17 | 0.27 | 0.22 | 0.24 | 0.15 | 0.03 | — | — | — |
| Equity / assets | 78.5% | 67.9% | 73.6% | 74.0% | 79.1% | 93.4% | −29.8% | −30.0% | −83.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $110.5M | $118.3M | $128.7M | $135.5M | $142.8M | $152.4M | $98.6M | $112.7M | $123.0M | $115.2M | $131.4M | $144.3M |
| Cash & equivalents | $19.2M | $30.1M | $21.0M | $30.9M | $30.0M | $98.4M | $36.4M | $23.4M | $32.8M | $25.4M | $56.2M | $58.0M |
| Short-term investments | $91.3M | $88.2M | $107.7M | $104.6M | $112.8M | $54.0M | $62.1M | $89.3M | $90.2M | $89.8M | $75.2M | $86.3M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $4.9M | $4.7M | $3.8M | $3.5M | $3.9M | $3.3M | $2.6M | $2.9M | $3.8M | $3.6M | $2.6M | $2.8M |
| Total current assets | $115.4M | $123.0M | $132.4M | $139.0M | $146.7M | $155.7M | $101.2M | $115.5M | $126.8M | $118.8M | $134.0M | $147.0M |
| Property, plant & equipment (net) | $310,000 | $9.1M | $9.7M | $17.8M | $18.7M | $19.5M | $20.4M | $21.2M | $22.1M | $22.9M | $23.7M | $24.5M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $9.3M | $860,000 | $902,000 | $944,000 | $985,000 | $1.0M | $1.1M | $1.1M | $1.2M | $819,000 | $823,000 | $819,000 |
| Total assets | $125.0M | $132.9M | $143.0M | $157.7M | $166.4M | $176.2M | $122.6M | $137.9M | $150.0M | $142.5M | $158.6M | $172.4M |
| Liabilities | ||||||||||||
| Accounts payable | $1.4M | $3.0M | $579,000 | $975,000 | $771,000 | $2.6M | $4.0M | $2.0M | $763,000 | $1.2M | $2.3M | $694,000 |
| Short-term debt | $3.9M | $3.8M | $3.7M | $3.6M | $3.8M | $3.7M | $3.4M | $3.3M | $3.3M | $3.2M | $3.1M | $3.0M |
| Deferred revenue | — | — | — | — | — | — | — | −$3.3M | — | — | — | −$3.0M |
| Total current liabilities | $15.8M | $14.5M | $15.7M | $15.5M | $16.8M | $16.8M | $20.6M | $20.8M | $18.4M | $16.9M | $19.6M | $15.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $17.0M | $17.9M | $18.8M | $19.7M | $20.8M | $21.6M | $22.2M | $23.0M | $23.8M | $24.5M | $25.3M | $26.0M |
| Other long-term liabilities | $13.1M | $14.1M | $15.1M | $16.0M | $17.0M | $17.9M | $18.8M | $19.7M | $20.5M | $21.4M | $22.2M | $23.0M |
| Total liabilities | $28.9M | $28.6M | $30.8M | $31.6M | $33.8M | $34.7M | $39.4M | $40.5M | $39.0M | $38.2M | $41.8M | $38.1M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $8,000 | $8,000 | $8,000 | $8,000 | $7,000 | $7,000 | $7,000 | $7,000 | $7,000 | $7,000 | $7,000 | $7,000 |
| Retained earnings (deficit) | −$483.7M | −$473.8M | −$464.7M | −$449.6M | −$441.1M | −$430.6M | −$487.1M | −$471.1M | −$455.6M | −$435.7M | −$417.4M | −$398.0M |
| Accumulated other comprehensive income | −$68,000 | −$36,000 | $101,000 | $142,000 | −$25,000 | −$19,000 | $24,000 | $107,000 | −$115,000 | −$95,000 | −$27,000 | −$364,000 |
| Total shareholders' equity | $96.1M | $104.3M | $112.2M | $126.2M | $132.6M | $141.5M | $83.3M | $97.4M | $111.0M | $104.3M | $116.7M | $134.3M |
| Key figures | ||||||||||||
| Total debt | $17.0M | $17.9M | $18.8M | $19.7M | $20.8M | $21.6M | $22.2M | $23.0M | $23.8M | $24.5M | $25.3M | $26.0M |
| Net cash (debt) | $93.5M | $100.4M | $109.9M | $115.8M | $122.1M | $130.8M | $76.4M | $89.7M | $99.2M | $90.7M | $106.1M | $118.2M |
| Working capital | $99.6M | $108.4M | $116.7M | $123.4M | $129.9M | $138.8M | $80.6M | $94.7M | $108.3M | $102.0M | $114.4M | $132.0M |
| Tangible book value | $96.1M | $104.3M | $112.2M | $126.2M | $132.6M | $141.5M | $83.3M | $97.4M | $111.0M | $104.3M | $116.7M | $134.3M |
| Book value per share | $1.68 | $1.82 | $1.97 | $2.22 | $2.33 | $2.45 | $1.47 | $1.72 | $2.01 | $2.01 | $2.46 | $2.64 |
| Shares outstanding | 57.4M | 57.2M | 57.1M | 56.9M | 56.8M | 57.7M | 56.6M | 56.5M | 55.2M | 51.8M | 47.4M | 50.9M |
| Current ratio | 7.28 | 8.46 | 8.42 | 8.94 | 8.73 | 9.24 | 4.92 | 5.55 | 6.87 | 7.05 | 6.82 | 9.76 |
| Quick ratio | 6.98 | 8.14 | 8.18 | 8.72 | 8.50 | 9.05 | 4.79 | 5.42 | 6.67 | 6.84 | 6.69 | 9.57 |
| Debt / equity | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 | 0.27 | 0.24 | 0.21 | 0.24 | 0.22 | 0.19 |
| Equity / assets | 76.9% | 78.5% | 78.5% | 80.0% | 79.7% | 80.3% | 67.9% | 70.7% | 74.0% | 73.2% | 73.6% | 77.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 16, 2026); data from EODHD.
BDTX financial position
At the end of fiscal 2025 (December 31, 2025), Black Diamond Therapeutics had total assets of $143.0 million (up 16.6% from a year earlier), total liabilities of $30.8 million and shareholders' equity of $112.2 million. It held $128.7 million in cash and short-term investments against $18.8 million of debt, a net cash position of $109.9 million. Its current ratio was 8.42. In the latest quarter (ended June 30, 2026) total assets were $125.0 million and equity $96.1 million.
Related: BDTX income statement, BDTX cash flow statement, BDTX key metrics. See the BDTX stock overview for the latest quote and news.
BDTX balance sheet FAQ
What are Black Diamond Therapeutics's total assets?
Black Diamond Therapeutics reported total assets of $143.0 million at the end of fiscal 2025 (December 31, 2025), compared with $122.6 million a year earlier.
How much debt does Black Diamond Therapeutics have?
Black Diamond Therapeutics had $18.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.17.
How much cash does Black Diamond Therapeutics have?
Black Diamond Therapeutics held $128.7 million in cash and short-term investments at the end of fiscal 2025; with $18.8 million of debt that is net cash of $109.9 million.
What is Black Diamond Therapeutics's book value?
Black Diamond Therapeutics's shareholders' equity (book value) was $112.2 million at the end of fiscal 2025, or $1.95 per share.
What is Black Diamond Therapeutics's current ratio?
Black Diamond Therapeutics had current assets of $132.4 million and current liabilities of $15.7 million, a current ratio of 8.42 (it can cover its short-term obligations).